Yubo International Biotech Stock Probability of Future Pink Sheet Price Finishing Over 0.03

YBGJ Stock  USD 0.04  0.0003  0.86%   
Yubo International's future price is the expected price of Yubo International instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Yubo International Biotech performance during a given time horizon utilizing its historical volatility. Check out Yubo International Backtesting, Yubo International Valuation, Yubo International Correlation, Yubo International Hype Analysis, Yubo International Volatility, Yubo International History as well as Yubo International Performance.
  
Please specify Yubo International's target price for which you would like Yubo International odds to be computed.

Yubo International Target Price Odds to finish over 0.03

The tendency of Yubo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.03  in 90 days
 0.04 90 days 0.03 
about 91.89
Based on a normal probability distribution, the odds of Yubo International to stay above $ 0.03  in 90 days from now is about 91.89 (This Yubo International Biotech probability density function shows the probability of Yubo Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Yubo International price to stay between $ 0.03  and its current price of $0.035 at the end of the 90-day period is under 4.
Given the investment horizon of 90 days Yubo International Biotech has a beta of -0.57. This entails as returns on the benchmark increase, returns on holding Yubo International are expected to decrease at a much lower rate. During a bear market, however, Yubo International Biotech is likely to outperform the market. Additionally Yubo International Biotech has an alpha of 0.6234, implying that it can generate a 0.62 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Yubo International Price Density   
       Price  

Predictive Modules for Yubo International

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Yubo International. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0419.02
Details
Intrinsic
Valuation
LowRealHigh
0.000.0319.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Yubo International. Your research has to be compared to or analyzed against Yubo International's peers to derive any actionable benefits. When done correctly, Yubo International's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Yubo International.

Yubo International Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Yubo International is not an exception. The market had few large corrections towards the Yubo International's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Yubo International Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Yubo International within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.62
β
Beta against Dow Jones-0.57
σ
Overall volatility
0.02
Ir
Information ratio 0.03

Yubo International Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Yubo International for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Yubo International can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Yubo International is way too risky over 90 days horizon
Yubo International has some characteristics of a very speculative penny stock
Yubo International appears to be risky and price may revert if volatility continues
Yubo International has high likelihood to experience some financial distress in the next 2 years
Yubo International Biotech currently holds 2.4 M in liabilities. Yubo International has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Yubo International until it has trouble settling it off, either with new capital or with free cash flow. So, Yubo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Yubo International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Yubo to invest in growth at high rates of return. When we think about Yubo International's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.24 B. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 820.65 K.
Yubo International Biotech currently holds about 36.58 K in cash with (1.02 M) of positive cash flow from operations.
Roughly 95.0% of the company outstanding shares are owned by insiders

Yubo International Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Yubo Pink Sheet often depends not only on the future outlook of the current and potential Yubo International's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Yubo International's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.2 M
Cash And Short Term Investments27.52

Yubo International Technical Analysis

Yubo International's future price can be derived by breaking down and analyzing its technical indicators over time. Yubo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Yubo International Biotech. In general, you should focus on analyzing Yubo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Yubo International Predictive Forecast Models

Yubo International's time-series forecasting models is one of many Yubo International's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Yubo International's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Yubo International

Checking the ongoing alerts about Yubo International for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Yubo International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Yubo International is way too risky over 90 days horizon
Yubo International has some characteristics of a very speculative penny stock
Yubo International appears to be risky and price may revert if volatility continues
Yubo International has high likelihood to experience some financial distress in the next 2 years
Yubo International Biotech currently holds 2.4 M in liabilities. Yubo International has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Yubo International until it has trouble settling it off, either with new capital or with free cash flow. So, Yubo International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Yubo International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Yubo to invest in growth at high rates of return. When we think about Yubo International's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.24 B. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 820.65 K.
Yubo International Biotech currently holds about 36.58 K in cash with (1.02 M) of positive cash flow from operations.
Roughly 95.0% of the company outstanding shares are owned by insiders

Other Information on Investing in Yubo Pink Sheet

Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.